vs
Side-by-side financial comparison of CAPITAL CITY BANK GROUP INC (CCBG) and Cytek Biosciences, Inc. (CTKB). Click either name above to swap in a different company.
CAPITAL CITY BANK GROUP INC is the larger business by last-quarter revenue ($63.5M vs $62.1M, roughly 1.0× Cytek Biosciences, Inc.). CAPITAL CITY BANK GROUP INC runs the higher net margin — 21.6% vs -70.9%, a 92.5% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs 6.0%). CAPITAL CITY BANK GROUP INC produced more free cash flow last quarter ($80.0M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 6.0%).
Texas Capital Bank is a bank headquartered in Dallas, Texas. The bank has branches located in every major city in Texas. Its parent bank holding company is Texas Capital Bancshares. It also operates an online-only banking division, Bask Bank.
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
CCBG vs CTKB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $63.5M | $62.1M |
| Net Profit | $13.7M | $-44.1M |
| Gross Margin | — | 52.9% |
| Operating Margin | 29.3% | -9.0% |
| Net Margin | 21.6% | -70.9% |
| Revenue YoY | 6.0% | 8.1% |
| Net Profit YoY | 4.7% | -557.1% |
| EPS (diluted) | $0.80 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $63.5M | $62.1M | ||
| Q3 25 | $65.9M | $52.3M | ||
| Q2 25 | $63.2M | $45.6M | ||
| Q1 25 | $61.5M | $41.5M | ||
| Q4 24 | $59.9M | $57.5M | ||
| Q3 24 | $59.7M | $51.5M | ||
| Q2 24 | $58.9M | $46.6M | ||
| Q1 24 | $56.5M | $44.9M |
| Q4 25 | $13.7M | $-44.1M | ||
| Q3 25 | $15.9M | $-5.5M | ||
| Q2 25 | $15.0M | $-5.6M | ||
| Q1 25 | $16.9M | $-11.4M | ||
| Q4 24 | $13.1M | $9.6M | ||
| Q3 24 | $13.1M | $941.0K | ||
| Q2 24 | $14.2M | $-10.4M | ||
| Q1 24 | $12.6M | $-6.2M |
| Q4 25 | — | 52.9% | ||
| Q3 25 | — | 52.7% | ||
| Q2 25 | — | 52.3% | ||
| Q1 25 | — | 48.6% | ||
| Q4 24 | — | 58.5% | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 54.6% | ||
| Q1 24 | — | 51.3% |
| Q4 25 | 29.3% | -9.0% | ||
| Q3 25 | 32.0% | -17.6% | ||
| Q2 25 | 31.7% | -23.3% | ||
| Q1 25 | 35.8% | -36.1% | ||
| Q4 24 | 29.0% | 5.2% | ||
| Q3 24 | 26.1% | -8.2% | ||
| Q2 24 | 29.3% | -18.3% | ||
| Q1 24 | 27.2% | -23.9% |
| Q4 25 | 21.6% | -70.9% | ||
| Q3 25 | 24.2% | -10.5% | ||
| Q2 25 | 23.8% | -12.2% | ||
| Q1 25 | 27.4% | -27.5% | ||
| Q4 24 | 21.9% | 16.8% | ||
| Q3 24 | 22.0% | 1.8% | ||
| Q2 24 | 24.0% | -22.4% | ||
| Q1 24 | 22.2% | -13.8% |
| Q4 25 | $0.80 | — | ||
| Q3 25 | $0.93 | — | ||
| Q2 25 | $0.88 | — | ||
| Q1 25 | $0.99 | — | ||
| Q4 24 | $0.78 | — | ||
| Q3 24 | $0.77 | — | ||
| Q2 24 | $0.83 | — | ||
| Q1 24 | $0.74 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $90.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $552.9M | $341.7M |
| Total Assets | $4.4B | $461.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $90.9M | ||
| Q3 25 | — | $93.3M | ||
| Q2 25 | — | $75.5M | ||
| Q1 25 | — | $95.3M | ||
| Q4 24 | — | $98.7M | ||
| Q3 24 | — | $162.3M | ||
| Q2 24 | — | $177.9M | ||
| Q1 24 | — | $168.8M |
| Q4 25 | $552.9M | $341.7M | ||
| Q3 25 | $540.6M | $378.6M | ||
| Q2 25 | $526.4M | $377.6M | ||
| Q1 25 | $512.6M | $379.6M | ||
| Q4 24 | $495.3M | $395.7M | ||
| Q3 24 | $476.5M | $385.5M | ||
| Q2 24 | $461.0M | $389.1M | ||
| Q1 24 | $448.3M | $392.6M |
| Q4 25 | $4.4B | $461.5M | ||
| Q3 25 | $4.3B | $494.9M | ||
| Q2 25 | $4.4B | $493.3M | ||
| Q1 25 | $4.5B | $482.6M | ||
| Q4 24 | $4.3B | $499.5M | ||
| Q3 24 | $4.2B | $491.2M | ||
| Q2 24 | $4.2B | $483.7M | ||
| Q1 24 | $4.3B | $492.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $87.6M | $-771.0K |
| Free Cash FlowOCF − Capex | $80.0M | $-1.8M |
| FCF MarginFCF / Revenue | 126.1% | -2.9% |
| Capex IntensityCapex / Revenue | 12.0% | 1.6% |
| Cash ConversionOCF / Net Profit | 6.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | $150.1M | $-8.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $87.6M | $-771.0K | ||
| Q3 25 | $21.6M | $-3.9M | ||
| Q2 25 | $32.6M | $108.0K | ||
| Q1 25 | $21.9M | $-125.0K | ||
| Q4 24 | $63.6M | $2.0M | ||
| Q3 24 | $12.8M | $13.2M | ||
| Q2 24 | $24.9M | $6.2M | ||
| Q1 24 | $14.6M | $4.0M |
| Q4 25 | $80.0M | $-1.8M | ||
| Q3 25 | $19.8M | $-4.6M | ||
| Q2 25 | $30.8M | $-1.5M | ||
| Q1 25 | $19.5M | $-974.0K | ||
| Q4 24 | $54.9M | $1.1M | ||
| Q3 24 | $10.5M | $12.2M | ||
| Q2 24 | $23.0M | $5.2M | ||
| Q1 24 | $12.4M | $3.4M |
| Q4 25 | 126.1% | -2.9% | ||
| Q3 25 | 30.1% | -8.7% | ||
| Q2 25 | 48.7% | -3.2% | ||
| Q1 25 | 31.7% | -2.3% | ||
| Q4 24 | 91.7% | 1.9% | ||
| Q3 24 | 17.6% | 23.7% | ||
| Q2 24 | 39.0% | 11.0% | ||
| Q1 24 | 22.0% | 7.6% |
| Q4 25 | 12.0% | 1.6% | ||
| Q3 25 | 2.6% | 1.3% | ||
| Q2 25 | 2.9% | 3.5% | ||
| Q1 25 | 3.9% | 2.0% | ||
| Q4 24 | 14.5% | 1.6% | ||
| Q3 24 | 3.8% | 2.0% | ||
| Q2 24 | 3.3% | 2.3% | ||
| Q1 24 | 4.0% | 1.3% |
| Q4 25 | 6.39× | — | ||
| Q3 25 | 1.35× | — | ||
| Q2 25 | 2.17× | — | ||
| Q1 25 | 1.30× | — | ||
| Q4 24 | 4.86× | 0.21× | ||
| Q3 24 | 0.97× | 14.05× | ||
| Q2 24 | 1.76× | — | ||
| Q1 24 | 1.17× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCBG
Segment breakdown not available.
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
